Introduction
This course describes the epidemiology and etiology of equine protozoal myeloencephalitis (EPM) along with current treatment approaches.
Learning Objectives
After participating in this program, the participant should be able to:
- Describe the epidemiology of EPM.
- Describe the etiology of EPM.
- Describe the appropriate selection of treatment for EPM.
- Discuss the characteristics of currently available pharmaceuticals for the treatment of EPM.
Target Audience
Pharmacists
Pharmacy Technicians
Author
William Howard, D.V.M.
Dr. Howard is a 1973 graduate of Texas A&M University College of Veterinary Medicine. Dr. Howard currently has a practice (Animal Clinic at the Crossing and West Loop Animal Hospital) with three other veterinarians in Longview, Texas, which focuses primarily upon equine and small animals with an emphasis on equine reproduction and dentistry. Dr. Howard is a member of the American Association of Equine Practitioners, American Veterinary Medical Association and East Texas Veterinary Medical Association of which he was president in 1979. He has continued his Texas A&M ties through research programs -- including most recently colic and rhodococcus studies in 1997 and 1998.
Contact Dr. Howard: acc@texramp.net
Language
English
Accreditation
ACPE UNIVERSAL PROGRAM NUMBER 288-000-07-158-H01-P.
Release Date: 11/29/2007
Expiration Date: 11/29/2010
PCCA is approved by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This activity will provide a total of 1.50 contact hour(s) (0.1500 CEU'S) of continuing education credit in states that recognize ACPE-approved providers.
